Clinical Trial Update: Effects of Simvastatin and Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the effects of simvastatin and micronized trans-resveratrol on polycystic ovary syndrome and insulin resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Polycystic Ovary Syndrome

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)
• Trans-resveratrol (micronized) (trans-resveratrol)

Snippet

Sponsor: Poznan University of Medical Sciences | Conditions: PCOS, Insulin Resistance | Phase 4 | Status: UNKNOWN